Department of Urology, Nanchong Central Hospital, The Second Clinical College, North Sichuan Medical College (University), Nanchong, Sichuan, China.
Int J Surg. 2023 Apr 1;109(4):995-1005. doi: 10.1097/JS9.0000000000000321.
Comparison of the perioperative outcomes of laparoscopic retroperitoneal lymph node dissection (L-RPLND) and open retroperitoneal lymph node dissection (O-RPLND) for low-stage (stage I/II) testicular germ cell tumors.
The authors performed a systematic review and cumulative meta-analysis of the primary outcomes of interest according to PRISMA criteria, and the quality assessment of the included studies followed the AMSTAR guidelines. Four databases were searched, including Embase, PubMed, the Cochrane Library, and Web of Science. The search period was from the creation of each database to October 2022. The statistical analysis software uses Stata17.
There were nine studies involving 579 patients. Compared with O-RPLND, L-RPLND was associated with shorter length of stay [weighted mean difference (WMD)=-3.99, 95% CI: -4.80 to -3.19, P <0.05], less estimated blood loss (WMD=-0.95, 95% CI: -1.35 to -0.54, P <0.05), shorter time to oral intake after surgery (WMD=-0.77, 95% CI: -1.50 to -0.03, P <0.05), and lower overall complications (odds ratio=0.58, 95% CI: 0.38-0.87, P <0.05). Subgroup analysis found that the complication rate of Clavien-Dindo grade II was lower in L-RPLND (odds ratio=0.24, 95% CI: 0.11-0.55, P <0.05). Interestingly, there was no statistically significant difference between the two groups in terms of operation time, lymph node yields, and recurrence rate during follow-up.
L-RPLND is superior to O-RPLND and is worthy of clinical promotion.
比较腹腔镜腹膜后淋巴结清扫术(L-RPLND)和开放式腹膜后淋巴结清扫术(O-RPLND)治疗低分期(I/II 期)睾丸生殖细胞肿瘤的围手术期结果。
作者根据 PRISMA 标准对主要感兴趣的结局进行了系统评价和累积荟萃分析,纳入研究的质量评估遵循 AMSTAR 指南。共检索了 4 个数据库,包括 Embase、PubMed、Cochrane 图书馆和 Web of Science。检索时间从每个数据库创建到 2022 年 10 月。统计分析软件使用 Stata17。
共有 9 项研究纳入 579 例患者。与 O-RPLND 相比,L-RPLND 具有更短的住院时间[加权均数差(WMD)=-3.99,95%可信区间(CI):-4.80 至-3.19,P<0.05]、更少的估计失血量(WMD=-0.95,95%CI:-1.35 至-0.54,P<0.05)、术后更早开始口服摄入(WMD=-0.77,95%CI:-1.50 至-0.03,P<0.05)和更低的总体并发症发生率(比值比=0.58,95%CI:0.38-0.87,P<0.05)。亚组分析发现,L-RPLND 组 Clavien-Dindo 分级 II 级并发症发生率较低(比值比=0.24,95%CI:0.11-0.55,P<0.05)。有趣的是,两组之间在手术时间、淋巴结产量和随访期间的复发率方面没有统计学上的显著差异。
L-RPLND 优于 O-RPLND,值得临床推广。